Skip to content

Clinical comprehensive evaluation of second-generation antipsychotic long-acting injectables in the treatment of schizophrenia

Clinical comprehensive evaluation of second-generation antipsychotic long-acting injectables in the treatment of schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116086
Enrollment
Unknown
Registered
2026-01-05
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Observation group:None
Control group:None

Sponsors

Shandong mental health center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Diagnosed with schizophrenia, aged = 18 years old; 2. Gender is not limited; 3. No racial restrictions.

Exclusion criteria

Exclusion criteria: 1. The patient has a diagnosis of other mental disorders besides schizophrenia; 2. There are obvious physical diseases, or the results of biochemical, blood and urine tests show obvious clinical abnormalities; 3. Those who have had severe allergic reactions to any antipsychotic drugs in the past; 4. Have a history of tardive dyskinesia or malignant syndrome caused by antipsychotic drugs; 5. Pregnant or lactating women or those planning to become pregnant; 6. There are obvious suicidal tendencies or violent behaviors; 7. There is intravenous drug use or there is drug dependence or alcohol dependence; 8. Patients who have used long-acting injections of second-generation antipsychotic drugs in the past six months; 9. Other circumstances where participation in this research is not suitable.

Design outcomes

Primary

MeasureTime frame
Positive and Negative symptom scale scores;

Secondary

MeasureTime frame
Clinical overall impression - Severity Scale score;Score of the Social Functioning Assessment Scale;

Countries

China

Contacts

Public ContactZhiqiang Li

Shandong mental health center

lizhiqiang6539@163.com+86 531 86336714

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026